Boehringer Ingelheim pioneers legal design on pharmaceutical market

DZP is supporting Boehringer Ingelheim in work on improving the transparency of internal documents. Boehringer Ingelheim is one of the first pharmaceutical companies in Poland to decide to apply legal design methodology.

Thanks to the use of modern tools to study the stylistic features of a text, the application of the plain language methodology and a user-friendly graphic form, the first draft of new contracts was created. Similar work was also carried out for other of the company’s internal documents.

“I am very pleased that the pharmaceutical sector sees the value in simplifying the language of contracts and internal documentation using legal design. Specific legal and sector regulations impose additional obligations on entities operating in this sector, which often makes contracts very extensive and difficult to understand. Adapting documents to business needs, while meeting legal requirements, facilitates the work of each of the parties.” says Anna Partyka-Opiela, Partner and Head of the Compliance Team.

Andrzej Bajor, Chief Legal&Compliance Officer at Boehringer Ingelheim, points out that “we see a significant business value in simplifying our contracts and procedures. The first version of the contracts provided, amended through the legal design methodology, was met with great enthusiasm. We believe that more accessible document content will improve the quality of our contacts with both employees and particularly the medical community”.

Boehringer Ingelheim belongs to an international group and is one of the world's leading pharmaceutical companies. It develops, produces and sells innovative medicinal products of high therapeutic value for use in human and veterinary medicine.